920966-16-1

Basic information

• Product Name: Benzyl Cis-3-Hydroxymethylcyclohexylcarbamate
• Synonyms: Benzyl Cis-3-Hydroxymethylcyclohexylcarbamate;cis-3-(Boc-aMino)cyclohexaneMethanol, 97%;cis-3-(Benzyloxycarbonylamino)cyclohexanemethanol;tert-butyl (rel-(1S,3R)-3-(hydroxymethyl)cyclohexyl)carbamate
• CAS NO: 920966-16-1
• Molecular Formula: C15H21NO3
• Molecular Weight: 229.32
• Mol File: 920966-16-1.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Benzyl Cis-3-Hydroxymethylcyclohexylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: Benzyl Cis-3-Hydroxymethylcyclohexylcarbamate(920966-16-1)
• EPA Substance Registry System: Benzyl Cis-3-Hydroxymethylcyclohexylcarbamate(920966-16-1)

Safety Data

• Hazardous Substances Data: 920966-16-1(Hazardous Substances Data)

Usage

General Description

Benzyl cis-3-hydroxymethylcyclohexylcarbamate is a chemical compound commonly used as an active ingredient in insect repellents and personal care products. It is known for its ability to repel mosquitoes and other insects, making it a popular choice for outdoor use. The compound is a carbamate derivative that acts as a repellent by interfering with the insect's ability to detect carbon dioxide, which is a key factor in their attraction to human hosts. Benzyl cis-3-hydroxymethylcyclohexylcarbamate is considered to be a safe and effective ingredient when used as directed, and it is widely used in products designed to protect against insect bites.

Upstream product

• 98-88-4 benzoyl chloride 
• 849410-73-7 methyl 3-[(tert-butoxycarbonyl)amino]cyclohexanecarboxylate 
• 541-41-3 chloroformic acid ethyl ester 
• 334932-13-7 3-[(tert-butoxycarbonyl)amino]cyclo-hexanecarboxylic acid 
• 218772-92-0 cis-3-[(tert-butoxycarbonyl)amino]-cyclohexanecarboxylic acid 
• 222530-34-9 (1S,3R)-3-((tert-butoxycarbonyl)amino)cyclo hexane-1-carboxylic acid 
• 218772-92-0 racemic trans-3-((tert-butoxycarbonyl)amino)cyclohexane-1-carboxylic acid 
• 218772-92-0 (±)-cis-3-((tert-butoxycarbonyl)amino)cyclohexanecarboxylic acid 

Downstream Products

• 1607590-84-0 tert-butyl (3-formylcyclohexyl)carbamate 
• 1607590-85-1 tert-butyl {3-[2-cyanovinyl]cyclohexyl}carbamate 
• 1607590-86-2 3-(3-aminocyclohexyl)acrylonitrile hydrochloride 
• 1607590-87-3 3-{3-[(6-nitrothieno[3,2-b]pyridin-7-yl)amino]cyclohexyl}acrylonitrile 
• 1607590-88-4 3-{3-[(6-aminothieno[3,2-b]pyridin-7-yl)amino]cyclohexyl}propanenitrile 
• 1607590-83-9 3-(3-{2-[(1R)-1-hydroxyethyl]-1H-imidazo[4,5-d]thieno[3,2-b]pyridin-1-yl}cyclohexyl)propanenitrile 
• 347186-61-2 tert-butyl (3-(aminomethyl)cyclohexyl)carbamate 

Relevant articles and documents

P2X3 MODULATORS

Provided herein are P2X3 modulators and methods of utilizing P2X3 modulators in the treatment of diseases, disorders, or conditions. Also described herein are pharmaceutical compositions containing such compounds.

Pyrimidine amine compound, and preparation method and application thereof

The invention discloses a polycyclic compound, and a preparation method and an application thereof. The invention provides the polycyclic compound represented by formula I, or a pharmaceutically acceptable salt thereof. The compound has a relatively good inhibition effect on CDK7.

INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)

The present invention provides novel compounds of Formula (I) and Formula (II) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are methods and kits involving the compounds or compositions for treating or preventing proliferative diseases (e.g., cancers (e.g., leukemia, melanoma, multiple myeloma), benign neoplasms, angiogenesis, inflammatory diseases, autoinflammatory diseases, and autoimmune diseases) in a subject. Treatment of a subject with a proliferative disease using a compound or composition of the invention may inhibit the aberrant activity of cyclin-dependent kinase 7 (CDK7), and therefore, induce cellular apoptosis and/or inhibit transcription in the subject.